Price board · 22 providers with a published tirzepatide rate
The cheapest tirzepatide when you are taking a fraction of a dose
Every other “cheapest tirzepatide” page ranks on cost per month. If you are deliberately holding at a low dose, that is the wrong denominator: you are buying a quarter of the drug a full-dose patient buys, and on a flat-priced plan you are paying the full-dose rate for it. So this board asks a narrower question — which of these companies actually charges you less when you take less — and orders on the answer.
Two things follow from that, and they are the whole argument of this page. The first is that the lowest advertised number is often not the cheapest way to take a low dose — several of the cheapest headline rates here are flat-at-every-dose plans, which is a genuine selling point if you intend to titrate up and a straight overpayment if you do not. The second is that a price you cannot read until after an intake quiz cannot be ranked at all, so six providers that do sell tirzepatide are listed further down by name rather than seated somewhere in the middle of this table.
Before the prices: deliberately microdosing a GLP-1 is off-label and unproven. There is no randomised trial of sub-therapeutic tirzepatide for weight or metabolic outcomes, and a dose-response relationship that is real is precisely the reason a fraction of a dose should not be expected to do a full dose’s work. This page ranks what providers charge, not what a small dose achieves — read the evidence review first.
Every published tirzepatide rate
22 providers · monthly cost
Partners first, then everyone else — the same partition used across this site and described in our disclosure. Inside each group the order is by what the pricing does when you take less, best first. It is not a merit ranking and the figures below are not sorted low to high.
Each figure is the provider's own published price, printed word for word with its terms intact — a yearly-subscription rate and a month-to-month rate are different numbers and are not flattened into one. Where a row reads “not one flat figure”, something is billed on top of the medication. Verified against each provider's site in 2026; confirm before you buy.
What each price does when you take less
This is the sort the other cheapest-tirzepatide pages do not run. Same providers, same published figures, grouped by what happens to the bill at a quarter dose. Some of these structures are fine for someone titrating up to a full dose and poor value for someone who has decided to stay small; the grouping is the point, not the order of the rows inside it.
Charges less for less
7 providers
Publishes a named low-dose product at a lower price than its own full-dose equivalent. Taking a smaller amount genuinely costs less here, which is the structure this page is looking for.
Two named microdose programmes, each with its own flat monthly rate and a stated dose ceiling, priced beneath the full-dose market rather than as the bottom rung of one.
Launched a dedicated GLP-1 microdosing programme in Oct 2025; the row records the advertised entry rate as the microdose tier and realistic ongoing cost as meaningfully higher.
Gala Health— $149/mo micro tirz (yearly subscription)
Prices a compounded microdose tirzepatide tier below its own standard tier — on a yearly subscription, which the row flags in its own words.
Sells microdosed tirzepatide as its own SKU, priced below its own full-dose tirzepatide — the row calls this the structure the site's rule was written to reward, and flags that every figure is an as-low-as tied to plan length.
Publishes a named Microdose line for both molecules on its own four-rung ladder, priced well beneath its own standard weight-loss line — the row records the month-to-month rung separately from the annual one because the marketing quotes the annual.
Quotes off the lowest dose
1 provider
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general board that is a warning; for someone staying small it is the one model that bills accordingly.
The row records that its funnel states its figures are based on the lowest dosage rates and that higher doses may cost more — the only row on the board that says so.
Prices the low dose on its own
3 providers
Publishes a price for a microdose track, but no standard-dose price alongside it — so you can cost the low dose, you just cannot see what it saves you.
Publishes microdose tracks for both molecules at their own rate, with no standard-dose price alongside to compare against, and the visit billed separately.
Both molecules appear as named Microdose Programs with public from-prices, but the row records that no standard-dose figure could be read beside them and that the card never states what period either figure covers.
A microdose tirzepatide protocol is the entire product and its care-inclusive price is public, so the low dose can be costed exactly — but there is no standard-dose product on the site to measure that saving against.
Same price at every dose
3 providers
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
Publishes one figure across its entire dose range for each molecule; the row calls the flat structure the least economical on the board for anyone staying small.
Its microdose line is flat at any strength, which the row scores as a cost rather than a comfort here: the flat microdose figure lands above the first rung of the provider's own published per-dose ladder, so taking less is billed at a premium.
Standard plan, self-directed low dose
8 providers
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
The row states outright that this is standard-dose compounded GLP-1, not a dedicated microdosing programme, so starting low means self-directing inside a standard plan.
Low headline pricing on standard compounded plans in both injectable and oral formats, with no low-dose tier of its own and advertised prices described as floors.
All-inclusive pricing per format with no membership, but no separately published low-dose rate; the row also marks the figures company-stated rather than live-verified.
Prices by FORMAT rather than by dose — the row's point is that a drop or lozenge is a forgiving vehicle for a fraction of a dose, not that a fraction costs less.
Sells the sublingual lozenge at the same price as the injection, so the dose-flexible format costs nothing extra — but the price is per plan, not per dose.
Each price above is the provider's own published figure, printed word for word with the terms attached to it — a yearly-subscription rate and a month-to-month rate are not the same number and are not collapsed into one here. We do not publish a cost per milligram: that needs the vial strength and the milligrams dispensed per month, and most of these providers publish neither, so the arithmetic would be ours rather than theirs. Where a provider publishes no low-dose price at all, that is recorded as the finding rather than filled in with an estimate.
The three worth reading in full
Not the three cheapest. The three at the top of the partner group whose pricing structure rewards a low dose — with the trade-offs each of them would rather you skipped, printed on the card.
1
CoreAge Rx
Doctor-reviewed low-dose GLP-1 protocols with flat pricing and built-in human support.
U.S.-licensed clinicians review an online intake, then a low-dose GLP-1 protocol is filled by a 503A compounding pharmacy. CoreAge runs two longevity-oriented programs: a Semaglutide Microdose (up to 0.125 mg, $79/mo) and a Tirzepatide Microdose (dual GIP/GLP-1, up to 1.25 mg, $129/mo), framed for metabolic baseline and appetite — not aggressive weight loss. Every plan includes 1:1 nurse and registered-dietitian consults, an automatic refund if you are not approved, and roughly 2-business-day shipping. Monthly recurring, with no separate membership or lab fee.
Strengths
Transparent flat pricing — $79/mo semaglutide, $129/mo tirzepatide, with no membership or lab surcharge
Doctor-reviewed protocols filled by a 503A compounding pharmacy
Included 1:1 support from nurses and registered dietitians
Automatic refund if you are not approved for treatment
Explicit low-dose, longevity-and-metabolic framing rather than max-dose weight-loss marketing
Trade-offs
Focused on low-dose metabolic protocols — not a full-titration weight-loss clinic
Like all compounded GLP-1s, the product is not FDA-approved, and intentional microdosing is off-label and unproven (see our evidence review)
Start with CoreAge Rx — from $79/moMicrodosing is off-label and unproven — decide with a clinician. Prices verified in 2026; confirm current terms.
2
Found
Established, physician-designed weight-care telehealth with a broad formulary, real coaching, and a new GLP-1 microdosing program.
From $99/mo (compounded, varies)
Main trade-off: Compounded semaglutide/tirzepatide are not FDA-approved, and intentional microdosing is off-label and unproven
Full review — 6 strengths, 4 trade-offs+−
Pricing in full: Compounded semaglutide/tirzepatide from $99/mo (entry/microdose; realistic ~$199–$399/mo, cheapest tiers need 3–12-month prepay) · brand path (Wegovy/Ozempic/Zepbound/Mounjaro) adds ~$39/mo membership · oral Rybelsus available · HSA/FSA eligible
Found (joinfound.com, Found Health Inc.) has run physician-designed weight care since 2019 and reports 250k+ members. An intake is reviewed by obesity-medicine clinicians, then care is paired with a behavioral-coaching program — app, 1:1 coaching, and community — plus insurance navigation. The formulary is unusually broad: compounded semaglutide and tirzepatide, brand-name Wegovy/Ozempic/Zepbound/Mounjaro, oral Rybelsus, and even non-GLP oral options, prescribed in all 50 states. In October 2025 Found launched a dedicated GLP-1 microdosing program, which is directly relevant to a start-low approach. Pricing is layered rather than flat: a compounded entry advertised 'as low as $99/mo' (the microdose/entry tier), with realistic ongoing cost around $199–$399/mo, and the cheapest rates requiring a 3–12-month prepay; the brand pathway stacks a ~$39/mo membership on top.
Strengths
Established since 2019 with 250k+ members — a real track record, not a fly-by-night operator
Obesity-medicine clinicians, not just a prescription mill
Broad formulary: compounded semaglutide/tirzepatide, brand Wegovy/Ozempic/Zepbound/Mounjaro, and oral Rybelsus
Dedicated GLP-1 microdosing program (launched Oct 2025) suited to a start-low approach
Real behavioral coaching, app, and community alongside the medication
Insurance navigation, HSA/FSA eligibility, and prescribing in all 50 states
Trade-offs
Compounded semaglutide/tirzepatide are not FDA-approved, and intentional microdosing is off-label and unproven
Layered pricing: the $99/mo figure is the entry/microdose tier — realistic ongoing cost runs higher, and the cheapest rates require a 3–12-month prepay
The brand pathway stacks a ~$39/mo membership fee on top of the medication
Cost and coverage vary meaningfully by state and insurance plan
Visit FoundMicrodosing is off-label and unproven — decide with a clinician. Prices verified in 2026; confirm current terms.
3
Gala Health
Both molecules in all 50 states with a microdose tier priced below the standard one — on a yearly subscription.
$149/mo micro tirz (yearly subscription)
Main trade-off: Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Full review — 5 strengths, 5 trade-offs+−
Pricing in full: $149/mo microdose tirzepatide and $179/mo standard compounded, both on a yearly subscription · $199/mo on a 3-month plan · brand Ozempic from $1,299/mo · no month-to-month rate published
An online intake is reviewed by Gala's clinical team (AI Coaching, Inc., with care delivered through OpenLoop-affiliated medical groups), then compounded semaglutide or tirzepatide is shipped to you. The prices are public rather than quiz-gated, which is worth something on this board — but every one of them is a yearly commitment: the $179/mo headline sits directly above the words "All doses included. Yearly subscription", the $149/mo microdose tier carries the same term, and the shortest plan quoted anywhere is $199/mo over three months. Gala is LegitScript-verified, markets itself as a women's brand ("dosed for women's bodies"), states all 50 states without publishing a list, and runs a full HRT/menopause line beside the metabolic one. A brand-name pathway (Ozempic from $1,299/mo) sits alongside the compounded arm.
Strengths
A microdose tirzepatide tier priced BELOW the standard tier at $149/mo — the structure this board is looking for, if you can commit to a year
Prices are published openly rather than held behind an intake quiz, so a plan can be costed before you sign up
Prescribes in all 50 states — one of the widest footprints in this list
Offers a brand-name GLP-1 pathway in addition to compounded, so patients can switch tracks
Adjacent HRT/menopause care for patients combining metabolic and hormone treatment
Trade-offs
Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
⚠ Every published rate is a yearly subscription — the $179 headline is printed above "All doses included. Yearly subscription" and the $149 microdose tier carries the same term, so the low figure is not a monthly price you can actually buy by the month
The brand-name pathway (from $1,299/mo) is far pricier than the compounded microdose tier
No oral/sublingual option yet — injectable only, so a small dose means drawing a partial unit
Neither the dispensing pharmacy (only "a wide network") nor a single clinician is named, by a newer operator with a short public record
Visit Gala HealthMicrodosing is off-label and unproven — decide with a clinician. Prices verified in 2026; confirm current terms.
Sells tirzepatide, would not tell us the price
These 7 providers all offer a tirzepatide path and none of them publish a figure a reader can check before starting an intake. They are absent from the table above for that reason and no other. A price behind a quiz is not a cheap price or an expensive one; it is an unknown, and seating it mid-table would imply we had seen it.
Sesame Care— Established national telehealth marketplace with the widest real brand-name GLP-1 access and top-tier trust signals.
Trimi— A microdose-first telehealth program built around low, longevity-oriented GLP-1 dosing at one flat monthly price.
Care Bare Rx— Oral tirzepatide as well as injectable, plus oral Rybelsus — but no price you can see before the quiz.
Wellorithm— Both molecules as dissolving tablets — and no way to find out what a small dose costs.
Noom Med— Branded-first GLP-1 program with a microdose track, bundled into a coaching subscription.
Ivy Rx— Dedicated microdose specialist with one flat price across every dose in the program.
Levers Health— Separates "microdose" from "low-dose" as two different products — and bills the microdose every other month.
What would change this ranking
One number, and none of these companies publish it: how many milligrams of tirzepatide arrive per month. With the vial strength and the monthly quantity, a genuine cost per milligram could be computed and this board could be sorted on it properly — and the order would almost certainly change, because a provider shipping a 10 mg vial for a 2.5 mg-per-month microdoser is selling four months of drug in one shipment while another sells one.
We are not going to estimate it. Multiplying an unpublished vial size by a published price would produce a figure that reads as measured and is not, which is precisely the failure this page criticises other boards for. So the ranking basis stays what providers actually disclose: the structure of the price, the terms attached to it, and whether it exists in public at all. If you are reconstituting a vial yourself, our reconstitution calculator will at least tell you how many doses your own vial holds, which is the same arithmetic from the only end where the inputs are known — yours.
What is the cheapest tirzepatide if I am only taking a low dose?
It depends on whether the provider charges less when you take less. Some publish a named microdose tier below their own full-dose price, so a smaller amount genuinely costs less. Others charge one figure at every dose, which means a quarter dose costs what a full one does. The lowest headline number on a board is frequently the second kind, so the cheapest advertised price and the cheapest way to take a low dose are often different providers.
Is compounded tirzepatide always cheaper than the brand?
No, and it is a claim that has quietly gone out of date. Self-pay brand-name pricing has fallen far enough to overlap the compounded range: our own board carries brand Zepbound at $349 to $499 a month through a manufacturer channel, which sits inside the spread of the compounded plans listed here. Compounded tirzepatide is not FDA-approved and is not the same product as Mounjaro or Zepbound, so this is a comparison to run on your own dose rather than an assumption to carry over from the shortage years.
Why do you not publish a cost per milligram?
Because it would be our arithmetic rather than the provider's. A genuine cost per milligram needs the vial strength and the milligrams dispensed each month, and almost none of these companies publish either. Multiplying an unpublished vial size by a published monthly price produces a figure that looks measured and is not, which on a page about pricing honesty would be the worst possible thing to do.
Does a lower dose of tirzepatide still work?
There is no randomised trial of deliberately sub-therapeutic tirzepatide dosing for weight or metabolic outcomes, so the honest answer is that nobody knows how much of the full-dose effect a microdose retains. Full-dose tirzepatide trials are strong and the dose-response relationship is real, which is exactly why a fraction of a dose should not be expected to deliver a full result.